Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

FACTOR XIII (13) SCREEN

Geisinger Epic Procedure Code:  LAB2261    Geisinger Epic ID:  7134

SPECIMEN COLLECTION
Specimen type: 

Platelet-poor plasma


Preferred collection container: 
Alternate collection container: 
Other size blue-top (3.2% sodium citrate) tubes (e.g., 1.8 mL, 4.5 mL)
Specimen required: 

1 mL plasma aliquot for a single factor study. Each additional factor study requires an additional 0.5 mL aliquot. Samples requiring heparin neutralization require an additional 0.5 mL for each factor.


Special notes: 
  • If the patient’s hematocrit (HCT) is >55%, the volume of anticoagulant in the tube must be adjusted. Contact a performing location for sodium citrate adjusted tubes or instruction for how to adjust the sodium citrate.
  • When possible, use fresh venipuncture.
  • Avoid prolong tourniquet time (< 1 minute) and hemolysis during collection as this will alter results.
  • If indwelling catheter or butterfly collection device must be used, draw sample from a non-heparinized lumen or flush the line with 5 mL of saline and discard the first 10 mL of blood.
  • Tubes should be >90% filled.
  • Immediately mix gently after collection by inverting the tube end over end 5 to 6 times. Avoid vigorous mixing or additional inversion. Observe for the presence of clots or hemolysis and recollect if observed.


SPECIMEN PROCESSING
Processing instructions: 

Centrifuge specimen immediately at designated time and speed to obtain platelet-poor plasma (<10,000/µL). Using a plastic pipette, carefully remove plasma from cells, avoiding platelet/buffy layer by leaving a thin layer of plasma on top the cells. The centrifuged plasma should be aliquoted (1 mL per aliquot) into clearly labeled polypropylene tubes. The number of tests ordered will determine the aliquots needed. Check the residual specimen for clot and if present discard sample and redraw specimen. If plasma is icteric, lipemic or hemolyzed a lab comment should be generated to notify staff. Freeze upright in non-thaw freezer.


Transport temperature: 

Frozen on dry ice


Specimen stability: 

Room temperature: 4 hours 
Frozen (plasma) -20°C: 2 weeks 
Frozen (plasma) -70°C: 6 months


Rejection criteria: 

Clotted, hemolyzed, improperly filled tubes, improper anticoagulant ratio (HCT >55% and citrate not adjusted), refrigerated specimens, or stability exceeded.

Note: Specimen suspected of thawing in transport, indicated by slant in aliquot or specimen in lid of tube, will have testing performed, and the comment “interpret results with caution as thawing suspected” added to results.



TEST DETAILS
Reference interval: 

Clot intact after 24 hours 
Negative for deficiency


Additional information: 

Anticoagulation Impact on Coagulation Tests


CPT code(s):  85291
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Test includes: 

Factor XIII screen.


Methodology: 
Urea solubility, macroscopic Inspection
Synonyms: 

Factor XIII, Factor 13, FA13, Urea Solubility, Fibrin stabilizing factor


Clinical significance: 

Factor XIII crosslinks fibrin to stabilize blood clot. It’s deficiency or absence may cause delayed bleeding in patients relative to the injury, such as bleeding from the umbilical cord or the development of bleeding several hours after surgery. This is a qualitative assay and cannot detect mild factor XIII deficiency. If concerned for factor XIII deficiency persists after testing consider sending out for factor XIII activity level.


Doctoral Director(s): 
Michelle Grant DO
Review Date:  03/04/2025

Performing Locations